159 related articles for article (PubMed ID: 16634030)
21. Phenotypic commonalities in familial and sporadic Parkinson disease.
Baba Y; Markopoulou K; Putzke JD; Whaley NR; Farrer MJ; Wszolek ZK; Uitti RJ
Arch Neurol; 2006 Apr; 63(4):579-83. PubMed ID: 16606772
[TBL] [Abstract][Full Text] [Related]
22. Fracture risk after the diagnosis of Parkinson's disease: Influence of concomitant dementia.
Melton LJ; Leibson CL; Achenbach SJ; Bower JH; Maraganore DM; Oberg AL; Rocca WA
Mov Disord; 2006 Sep; 21(9):1361-7. PubMed ID: 16703587
[TBL] [Abstract][Full Text] [Related]
23. Differences in age at onset and familial aggregation between clinical types of idiopathic Parkinson's disease.
Korchounov A; Schipper HI; Preobrazhenskaya IS; Kessler KR; Yakhno NN
Mov Disord; 2004 Sep; 19(9):1059-64. PubMed ID: 15372596
[TBL] [Abstract][Full Text] [Related]
24. Increased risk of parkinsonism in women who underwent oophorectomy before menopause.
Rocca WA; Bower JH; Maraganore DM; Ahlskog JE; Grossardt BR; de Andrade M; Melton LJ
Neurology; 2008 Jan; 70(3):200-9. PubMed ID: 17761549
[TBL] [Abstract][Full Text] [Related]
25. Familial aggregation of Parkinson's disease: a meta-analysis.
Thacker EL; Ascherio A
Mov Disord; 2008 Jun; 23(8):1174-83. PubMed ID: 18442112
[TBL] [Abstract][Full Text] [Related]
26. Risk of cancer after the diagnosis of Parkinson's disease: a historical cohort study.
Elbaz A; Peterson BJ; Bower JH; Yang P; Maraganore DM; McDonnell SK; Ahlskog JE; Rocca WA
Mov Disord; 2005 Jun; 20(6):719-25. PubMed ID: 15704188
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-10 (IL10) and tumor necrosis factor alpha (TNF) gene polymorphisms in Parkinson's disease patients.
Bialecka M; Klodowska-Duda G; Kurzawski M; Slawek J; Gorzkowska A; Opala G; Bialecki P; Sagan L; Droździk M
Parkinsonism Relat Disord; 2008 Dec; 14(8):636-40. PubMed ID: 18362084
[TBL] [Abstract][Full Text] [Related]
28. A clinical-genetic study of Parkinson's disease in a genetically isolated community.
Dekker MC; van Swieten JC; Houwing-Duistermaat JJ; Snijders PJ; Boeren E; Hofman A; Breteler MM; Heutink P; Oostra BA; van Duijn CM
J Neurol; 2003 Sep; 250(9):1056-62. PubMed ID: 14504966
[TBL] [Abstract][Full Text] [Related]
29. Potential role of an additive genetic component in the cause of amyotrophic lateral sclerosis and parkinsonism-dementia in the western Pacific.
Bailey-Wilson JE; Plato CC; Elston RC; Garruto RM
Am J Med Genet; 1993 Jan; 45(1):68-76. PubMed ID: 8418664
[TBL] [Abstract][Full Text] [Related]
30. Study of familial Parkinson's disease in Russia, Uzbekistan, and Zambia.
Atadzhanov M; Zumla A; Mwaba P
Postgrad Med J; 2005 Feb; 81(952):117-21. PubMed ID: 15701745
[TBL] [Abstract][Full Text] [Related]
31. Familial aggregation of Parkinson's disease in Iceland.
Sveinbjörnsdottir S; Hicks AA; Jonsson T; Pétursson H; Guğmundsson G; Frigge ML; Kong A; Gulcher JR; Stefansson K
N Engl J Med; 2000 Dec; 343(24):1765-70. PubMed ID: 11114315
[TBL] [Abstract][Full Text] [Related]
32. Occupation and parkinsonism in three movement disorders clinics.
Goldman SM; Tanner CM; Olanow CW; Watts RL; Field RD; Langston JW
Neurology; 2005 Nov; 65(9):1430-5. PubMed ID: 16162857
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein E epsilon4 allele in familial and sporadic Parkinson's disease.
Blázquez L; Otaegui D; Sáenz A; Paisán-Ruiz C; Emparanza JI; Ruiz-Martinez J; Moreno F; Martí-Massó JF; López de Munain A
Neurosci Lett; 2006 Oct; 406(3):235-9. PubMed ID: 16904828
[TBL] [Abstract][Full Text] [Related]
34. 5,10-methylenetetrahydrofolate reductase C677T gene polymorphism can influence age at onset of Parkinson's disease.
Lin JJ; Yueh KC; Liu CS; Liu JT; Lin SZ
Acta Neurol Taiwan; 2007 Sep; 16(3):150-7. PubMed ID: 17966954
[TBL] [Abstract][Full Text] [Related]
35. Relationship of the Ubiquilin 1 gene with Alzheimer's and Parkinson's disease and cognitive function.
Arias-Vásquez A; de Lau L; Pardo L; Liu F; Feng BJ; Bertoli-Avella A; Isaacs A; Aulchenko Y; Hofman A; Oostra B; Breteler M; van Duijn C
Neurosci Lett; 2007 Aug; 424(1):1-5. PubMed ID: 17709205
[TBL] [Abstract][Full Text] [Related]
36. [Incidence and clinical profile of familial forms of Parkinson's disease. A study of 428 index-cases from a department of neurology].
Broussolle E; Defuentes G; Plauchu H; Chazot G
Rev Neurol (Paris); 1997 Jul; 153(6-7):406-11. PubMed ID: 9684007
[TBL] [Abstract][Full Text] [Related]
37. New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset.
Giladi N; Weitzman N; Schreiber S; Shabtai H; Peretz C
J Psychopharmacol; 2007 Jul; 21(5):501-6. PubMed ID: 17446202
[TBL] [Abstract][Full Text] [Related]
38. Chemical exposures and Parkinson's disease: a population-based case-control study.
Frigerio R; Sanft KR; Grossardt BR; Peterson BJ; Elbaz A; Bower JH; Ahlskog JE; de Andrade M; Maraganore DM; Rocca WA
Mov Disord; 2006 Oct; 21(10):1688-92. PubMed ID: 16773614
[TBL] [Abstract][Full Text] [Related]
39. Comorbid conditions associated with Parkinson's disease: a population-based study.
Leibson CL; Maraganore DM; Bower JH; Ransom JE; O'brien PC; Rocca WA
Mov Disord; 2006 Apr; 21(4):446-55. PubMed ID: 16161155
[TBL] [Abstract][Full Text] [Related]
40. [Study on the risk factors and its interaction on Parkinson disease].
Tan XH; Wang SM; Xue NQ; Teng WT; Feng YQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):527-30. PubMed ID: 15231138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
